Immediate Impact
3 by Nobel laureates 62 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Works of Xiaodong Pan being referenced
Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiaodong Pan | 79 | 271 | 87 | 130 | 13 | 386 | |
| Shilian Chen | 96 | 287 | 59 | 144 | 17 | 413 | |
| Chun Jin | 105 | 173 | 71 | 112 | 17 | 374 | |
| Ashley Eheim | 30 | 303 | 66 | 120 | 11 | 408 | |
| Dae-Ghon Kim | 65 | 277 | 41 | 149 | 12 | 421 | |
| Yilu Feng | 67 | 175 | 78 | 102 | 19 | 349 | |
| Yan Wu | 26 | 323 | 47 | 236 | 10 | 412 | |
| Rongrong Wei | 92 | 223 | 59 | 157 | 21 | 426 | |
| Shuoyi Jiang | 29 | 272 | 121 | 71 | 12 | 414 | |
| Kristy Kwan‐Shuen Chan | 53 | 246 | 83 | 119 | 19 | 454 | |
| Jingsun Wei | 72 | 181 | 42 | 137 | 22 | 356 |
All Works
Loading papers...